Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital
- 1 September 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (12) , 1447-1456
- https://doi.org/10.1007/s10096-009-0803-8
Abstract
The antimicrobial stewardship program (ASP) is a major strategy to combat antimicrobial resistance and to limit its expenditure. We have improved on our existing ASP to implement a sustainable and cost-effective two-stage immediate concurrent feedback (ICF) model, in which the antimicrobial prescription is audited by two part-time infection control nurses at the first stage, followed by “physician ICF” at the second stage. In January 2005, an ASP focused on broad-spectrum intravenous antibiotics was implemented. All in-patients, except from the intensive care, bone marrow transplantation, liver transplantation, pediatric, and private units, being treated with broad-spectrum intravenous antibiotics were included. The compliance to ICF and “physician ICF”, antibiotics usage density measured by expenditure and defined daily doses (DDD) were recorded and analyzed before and after the ASP. The overall conformance rate to antibiotic prescription guidelines was 79.4%, while the conformance to ICF was 83.8%. Antibiotics consumption reduced from 73.06 (baseline, year 2004) to 64.01 (year 2007) per 1,000 patient bed-day-occupancy. Our model can be easily applied even in the clinical setting of limited resources.Keywords
This publication has 37 references indexed in Scilit:
- Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosaInfection Control & Hospital Epidemiology, 2009
- Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypesDiagnostic Microbiology and Infectious Disease, 2007
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007
- Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)Diagnostic Microbiology and Infectious Disease, 2005
- Comparison of Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from Shanghai and Hong KongMedical Principles and Practice, 2005
- In Vitro Antienterococcal Activity Explains Associations between Exposures to Antimicrobial Agents and Risk of Colonization by Multiresistant EnterococciThe Journal of Infectious Diseases, 2004
- Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infectionsBritish Journal of Clinical Pharmacology, 2001
- Excessive Use of Vancomycin: A Successful Intervention Strategy at an Academic Medical CenterInfection Control & Hospital Epidemiology, 2000
- Hospital antibiotic prescribing successfully modified by ‘immediate concurrent feedback’British Journal of Clinical Pharmacology, 1996
- Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryDiagnostic Microbiology and Infectious Disease, 1993